Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobial or antibacterial. After the discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Market Overview and Dynamics
The North America antibiotics market is expected to reach US$ 18,004.25 million by 2027 from US$ 13,527.79 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases andincreasing development of generic drugs. However, the tedious and expensive process of antibiotic development and the impact of COVID-19 pandemic are likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the North Americaantibiotics market in 2019. In terms of action mechanism, cell wall synthesis inhibitors segment is expected to hold the largest market share of the antibioticsmarket by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources forAntibioticsmarket included in the report are, World Health Organization (WHO), Food and Drug Administration (FDA), American Society for Microbiology (ASM), Centers for Disease Control and Prevention (CDC), Center for Disease Dynamics, Economics & Policy (CDDEP), and others.
Reasons to buy the report
- To understand the antibiotics market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for antibiotics market
- Efficiently plan M&A and partnership dealsin antibiotics market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antibiotics market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region.
NORTH AMERICAANTIBIOTICSMARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Geography
- North America
- US
- Canada
- Mexico
Company Profiles
- Johnson & Johnson Services, Inc
- Bristol-Myers Squibb Company
- Eli Lilly and Company.
- Abbott
- Pfizer Inc
North America Antibiotics Market Strategic Insights
North America Antibiotics Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 13,527.79 Million |
| Market Size by 2027 | US$ 18,004.25 Million |
| CAGR (2020 - 2027) | 3.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Class
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Antibiotics Market Country and Regional Insights
